Spectrophotometric Determination of Metformin via Schiff Base Formation with 2-Hydroxy-1-Naphthaldehyde
Downloads
A sensitive and straightforward spectrophotometric technique for measuring metformin levels was established in this work. The process is reacting 2-hydroxy-1-naphthaldehyde in an acidic solution to create a Schiff base, which has a high absorbance at 453 nm and an orange-yellow hue that indicates Schiff base production. The calibration curve validated the quantitative approach by demonstrating a linear relationship for values between 2 and 23 µg/mL, as indicated by the correlation coefficient R² = 0.9995. The method's great sensitivity and accuracy were demonstrated by the molar absorbance of 3693.976 L/mol/cm² and the Sandel index sensitivity of 0.0767 µg/cm² with a recovery rate of 100.53%. With a standard deviation of 0.0479%, the accuracy and repeatability were good. Additionally, the quantification limit was 0.098 µg/mL and the detection limit was 0.032 µg/mL. This approach is thought to be extremely sensitive to the medication. Because the ratio between the reactant and the medication was 1:1, the correctness of the standard technique was checked using the Job approach and the suggested chemically equivalent molar ratio. The concentration of metformin in the pharmaceutical formulation was satisfactorily established using this approach.
[1] M. S. Derakhshan, M. R. Sohrabi, and M. Davallo, “Developed rapid spectrophotometric method for simultaneous quantitative determination of metformin and linagliptin mixture as antidiabetic drugs by artificial intelligence methodology in biological fluid and pharmaceutical sample,” Optik, vol. 241, p. 166922, 2021.
[2] O. M. Abdalla, A. M. Abdel-Megied, A. S. Saad, and S. S. Soliman, “Simultaneous spectrophotometric determination of compounds having relatively disparate absorbance and concentration ranges; application to antidiabetic formulation of linagliptin and metformin,” Spectrochim. Acta Part A Mol. Biomol. Spectrosc., vol. 203, pp. 112–117, 2018.
[3] D. S. El-Kafrawy, O. H. El-Shoubashy, A. E. Issa, and Y. A. Beltagy, “Green chromatographic methods for simultaneous micro-determination of empagliflozin, linagliptin with metformin and its pharmacopoeial impurities in pure form and triple combination tablets: A comparative study,” Sustain. Chem. Pharm., vol. 25, p. 100560, 2022.
[4] M. G. Fawzy, H. M. Hafez, W. E. Hassan, A. A. Mostafa, and R. A. Sayed, “Application of molecular docking approach in a novel eco-friendly impurity profiling HPLC-UV method for the simultaneous estimation of ternary hypoglycemic pharmaceutical mixture,” Microchem. J., vol. 182, p. 107856, 2022.
[5] H. S. Elbordiny, S. M. Elonsy, H. G. Daabees, and T. S. Belal, “Implementation of two sustainable chromatographic methods for the simultaneous micro-quantitation and impurity profiling of metformin and rosuvastatin in recently approved fixed dose pills: Greenness and whiteness studies,” Sustain. Chem. Pharm., vol. 30, p. 100885, 2022.
[6] M. I. El-Awady, A. M. El-Brashy, N. A. Abdallah, and F. A. Ibrahim, “Multicomponent spectrophotometric determination of a ternary mixture of widely-prescribed cardiovascular drugs by four different methods,” Spectrochim. Acta Part A Mol. Biomol. Spectrosc., vol. 295, p. 122573, 2023.
[7] A. M. Hegazy, R. M. Abdelfatah, H. M. Mahmoud, and M. A. Elsayed, “Two spectrophotometric methods for quantitative determination of some pesticides applied for cucumber in Egypt,” Beni-Suef Univ. J. Basic Appl. Sci., vol. 7, no. 4, pp. 598–605, 2018.
[8] H. W. Darwish, S. A. Hassan, M. Y. Salem, and B. A. El-Zeany, “Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide,” Spectrochim. Acta Part A Mol. Biomol. Spectrosc., vol. 113, pp. 215–223, 2013.
[9] M. Shi, X. Zheng, N. Zhang, Y. Guo, M. Liu, and L. Yin, “Overview of sixteen green analytical chemistry metrics for evaluation of the greenness of analytical methods,” TrAC Trends Anal. Chem., vol. 166, p. 117211, 2023.
[10] M. Sajid and J. Płotka-Wasylka, “Green analytical chemistry metrics: A review,” Talanta, vol. 238, p. 123046, 2022.
[11] J. Płotka-Wasylka, “A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index,” Talanta, vol. 181, pp. 204–209, 2018.
[12] N. Manousi, W. Wojnowski, J. Płotka-Wasylka, and V. Samanidou, “Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality,” Green Chem., vol. 25, no. 19, pp. 7598–7604, 2023.
[13] J. B. Nevado, C. G. Cabanillas, and F. Salinas, “Spectrophotometric resolution of ternary mixtures of salicylaldehyde, 3-hydroxybenzaldehyde and 4-hydroxybenzaldehyde by the derivative ratio spectrum-zero crossing method,” Talanta, vol. 39, no. 5, pp. 547–553, 1992.
[14] Y. E. Mostafa, F. Elsebaei, and M. E. S. Metwally, “Exploring fluorescence of metal nanoparticles for effective utility in drug sensing: A Promising 'on-off' fluorescence probe for analysis of cephalosporins is fabricated,” Spectrochim. Acta Part A Mol. Biomol. Spectrosc., vol. 303, p. 123184, 2023.
[15] N. A. Farid, N. F. Youssef, H. E. Abdellatef, and Y. A. Sharaf, “Spectrofluorimetric methods for the determination of mirabegron by quenching tyrosine and L-tryptophan fluorophores: Recognition of quenching mechanism by Stern Volmer relationship, evaluation of binding constants and binding sites,” Spectrochim. Acta Part A Mol. Biomol. Spectrosc., vol. 293, p. 122473, 2023.
[16] H. M. El-Sayed, H. E. Abdellatef, H. A. Hendawy, O. M. El-Abassy, and H. Ibrahim, “DoE-enhanced development and validation of eco-friendly RP-HPLC method for analysis of safinamide and its precursor impurity: QbD approach,” Microchem. J., vol. 190, p. 108730, 2023.
[17] D. N. Friedman, E. S. Tonorezos, and P. Cohen, “Diabetes and metabolic syndrome in survivors of childhood cancer,” Horm. Res. Paediatr., vol. 91, no. 2, pp. 118–127, 2019.
[18] Y. Fujita and N. Inagaki, “Metformin: clinical topics and new mechanisms of action,” Diabetol. Int., vol. 8, no. 1, pp. 4–6, 2017.
[19] J. S. Skyler et al., “Differentiation of diabetes by pathophysiology, natural history, and prognosis,” Diabetes, vol. 66, no. 2, pp. 241–255, 2017.
[20] U. Galicia-Garcia et al., “Pathophysiology of type 2 diabetes mellitus,” Int. J. Mol. Sci., vol. 21, no. 17, p. 6275, 2020.
[21] A. Titmuss, E. A. Davis, A. Brown, and L. J. Maple‐Brown, “Emerging diabetes and metabolic conditions among Aboriginal and Torres Strait Islander young people,” Med. J. Aust., vol. 210, no. 3, pp. 111–113, 2019.
[22] C. V. Rizos, T. D. Filippatos, and M. S. Elisaf, “Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes,” Expert Opin. Drug Metab. Toxicol., vol. 14, no. 1, pp. 117–125, 2018.
[23] S. B. Harris, “The power of two: an update on fixed-dose combinations for type 2 diabetes,” Expert Rev. Clin. Pharmacol., vol. 9, no. 11, pp. 1453–1462, 2016.
[24] A. M. Atiyah, A. A. Mohammed, and A. M. K. Ahmed, “Spectrophotometric determination of meloxicam in pure form and its pharmaceutical preparations via oxidative coupling reaction,” Bull. Pharm. Sci., Assiut Univ., vol. 47, no. 2, pp. 1049–1062, 2024.
[25] A. A. M. Al Rashidy, K. A. Al Badrany, and G. M. Al Garagoly, “Spectrophotometric determination of sulphamethoxazole drug by new pyrazoline derived from 2,4-dinitrophenylhydrazine,” Mater. Sci. Forum, vol. 1002, pp. 350–359, 2020.
[26] M. M. Aftan, A. A. Talloh, A. H. Dalaf, and H. K. Salih, “Impact para position on rho value and rate constant and study of liquid crystalline behavior of azo compounds,” Mater. Today: Proc., vol. 45, pp. 5529–5534, 2021.
[27] A. S. H. Al-Janabi and A. A. M. Al-Rashidy, “Spectrophotometric estimation of folic acid (vitamin B9) using an oxidative coupling method with (E)-N’-(1-(2-nitrophenyl)ethylidene) quinoline-6-carbohydrazide (M4),” Kimya Problemleri, vol. 24, no. 2, pp. 218–225, 2026.
[28] A. A. M. Alrashidy, O. A. Hashem, and K. A. A. Albadrany, “Spectrophotometric determination of vitamin C using indirect oxidation with a new organic dye,” Integr. Biomed. Res., vol. 8, no. 2, pp. 1–7, 2024.
[29] A. Atiyah, K. Hussein, and A. M. Ahmed, “Spectrophotometric determination of meloxicam in pure form and its pharmaceutical formulation following azo dye formation with 4-nitroaniline,” J. Turk. Chem. Soc. A: Chem., vol. 11, no. 4, pp. 1461–1472, 2024.
Copyright (c) 2026 American Journal of Biomedicine and Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
